Cargando…

1346 Flutisane Propionate in Prevention of Rhynitis Alergica with Children

Introduction: In childhood rhynitis alergica is medical and social problem. The nasal mucous membrane first gets in touch with a lot of causes, including causes of allergy. Objective: Improvement of quality of the life with children who are treated with Fluticasone propionate. Material and Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Timovski, I, Angelovska, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104546/
http://dx.doi.org/10.1203/00006450-201011001-01346
_version_ 1783512259004203008
author Timovski, I
Angelovska, V
author_facet Timovski, I
Angelovska, V
author_sort Timovski, I
collection PubMed
description Introduction: In childhood rhynitis alergica is medical and social problem. The nasal mucous membrane first gets in touch with a lot of causes, including causes of allergy. Objective: Improvement of quality of the life with children who are treated with Fluticasone propionate. Material and Methods: We processed the data from medical records of 58 children on the age of 6 and 12 years in the period of 2 years (2008 - 2009), and 43 children from them were put on prevention with Fluticasone propionate. For processing the data we used analytic and descriptive method. Results: We processed 58 cases with rhynitis alergica proved with: skin tests or RIDA screen tests, total IgE, eosinophyles in nose and drainage secretion. 15 children were put only on symptom's therapy, and 43 children were put on therapy with Fluticasone propionate in a period of a few months. With 9 children rhinitis alergica was followed by conjuctivitis alergica and they get antihistaminic medicaments. All children that were put on prevention had minimal symptoms of Rhynitis and they had normal physical activities and attend a school regularly. Conclusion: Suitable and therapy on time allows normal and healthy life and free activity with children who have proved rhynitis alergica.
format Online
Article
Text
id pubmed-7104546
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-71045462020-03-31 1346 Flutisane Propionate in Prevention of Rhynitis Alergica with Children Timovski, I Angelovska, V Pediatr Res Article Introduction: In childhood rhynitis alergica is medical and social problem. The nasal mucous membrane first gets in touch with a lot of causes, including causes of allergy. Objective: Improvement of quality of the life with children who are treated with Fluticasone propionate. Material and Methods: We processed the data from medical records of 58 children on the age of 6 and 12 years in the period of 2 years (2008 - 2009), and 43 children from them were put on prevention with Fluticasone propionate. For processing the data we used analytic and descriptive method. Results: We processed 58 cases with rhynitis alergica proved with: skin tests or RIDA screen tests, total IgE, eosinophyles in nose and drainage secretion. 15 children were put only on symptom's therapy, and 43 children were put on therapy with Fluticasone propionate in a period of a few months. With 9 children rhinitis alergica was followed by conjuctivitis alergica and they get antihistaminic medicaments. All children that were put on prevention had minimal symptoms of Rhynitis and they had normal physical activities and attend a school regularly. Conclusion: Suitable and therapy on time allows normal and healthy life and free activity with children who have proved rhynitis alergica. Nature Publishing Group US 2010 /pmc/articles/PMC7104546/ http://dx.doi.org/10.1203/00006450-201011001-01346 Text en © International Pediatrics Research Foundation, Inc. 2010 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Timovski, I
Angelovska, V
1346 Flutisane Propionate in Prevention of Rhynitis Alergica with Children
title 1346 Flutisane Propionate in Prevention of Rhynitis Alergica with Children
title_full 1346 Flutisane Propionate in Prevention of Rhynitis Alergica with Children
title_fullStr 1346 Flutisane Propionate in Prevention of Rhynitis Alergica with Children
title_full_unstemmed 1346 Flutisane Propionate in Prevention of Rhynitis Alergica with Children
title_short 1346 Flutisane Propionate in Prevention of Rhynitis Alergica with Children
title_sort 1346 flutisane propionate in prevention of rhynitis alergica with children
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104546/
http://dx.doi.org/10.1203/00006450-201011001-01346
work_keys_str_mv AT timovskii 1346flutisanepropionateinpreventionofrhynitisalergicawithchildren
AT angelovskav 1346flutisanepropionateinpreventionofrhynitisalergicawithchildren